Circular RNAs in tumor biology and immunology: molecular mechanisms and therapeutic implications
- 1Center for Molecular Oncology, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University
Abstract
Cancer immunotherapy has revolutionized oncology, yet its efficacy remains frequently constrained by the immunosuppressive tumor microenvironment (TME). Circular RNAs (circRNAs) are covalently closed RNA molecules generated through back-splicing. Their lack of free ends confers strong resistance to exonuclease degradation and high molecular stability. Within tumor cells, circRNAs govern multiple cancer hallmarks via diverse regulatory mechanisms. Beyond these cell-intrinsic functions, circRNAs can be secreted as intercellular messengers that enter and reshape the TME by modulating antitumor immunity. Clinically, the high stability of circRNAs in body fluids highlights their potential as non-invasive liquid biopsy biomarkers for cancer diagnosis and prognosis. Furthermore, beyond targeting endogenous circRNAs, engineered circRNAs encoding tumor antigens or immunomodulatory proteins represent a promising platform for cancer immunotherapy. In this article, we briefly summarize recent advances in the understanding of circRNAs in tumor biology and immunology.
Related
- Circular RNAs in Drug-Induced Cardiotoxicity: Roles, Mechanisms, and Therapeutic Potential.
- Targeting circular RNAs to overcome therapeutic resistance in liver cancer: from mechanisms to clinical prospects
- Translated Circular RNAs in Glioblastoma: Emerging Regulators of Tumor Progression, Molecular Heterogeneity and Therapeutic Resistance
- 106 Multiplex epitranscriptomic profiling reveals RNA modification signatures of immune activation and therapeutic response in cancer immunology
- The Role of Neutrophil Extracellular Traps (NETosis) in Systemic Lupus Erythematosus: Molecular Mechanisms, Pathogenic Roles, Diagnostic Biomarkers, and Emerging Therapeutic Strategies
BibTeX
@article{jiang2026circular,
title = {{Circular RNAs in tumor biology and immunology: molecular mechanisms and therapeutic implications}},
author = {Zhenyan Jiang and Yong Peng and Xiaojuan Yang},
journal = {Molecular Cancer},
year = {2026},
month = jun,
doi = {10.1186/s12943-026-02708-4},
url = {https://doi.org/10.1186/s12943-026-02708-4},
note = {CC BY},
}
RIS
TY - JOUR
TI - Circular RNAs in tumor biology and immunology: molecular mechanisms and therapeutic implications
AU - Zhenyan Jiang
AU - Yong Peng
AU - Xiaojuan Yang
PY - 2026
DA - 2026/06/01
JO - Molecular Cancer
DO - 10.1186/s12943-026-02708-4
UR - https://doi.org/10.1186/s12943-026-02708-4
AB - Cancer immunotherapy has revolutionized oncology, yet its efficacy remains frequently constrained by the immunosuppressive tumor microenvironment (TME). Circular RNAs (circRNAs) are covalently closed RNA molecules generated through back-splicing. Their lack of free ends confers strong resistance to exonuclease degradation and high molecular stability. Within tumor cells, circRNAs govern multiple cancer hallmarks via diverse regulatory mechanisms. Beyond these cell-intrinsic functions, circRNAs can be secreted as intercellular messengers that enter and reshape the TME by modulating antitumor immunity. Clinically, the high stability of circRNAs in body fluids highlights their potential as non-invasive liquid biopsy biomarkers for cancer diagnosis and prognosis. Furthermore, beyond targeting endogenous circRNAs, engineered circRNAs encoding tumor antigens or immunomodulatory proteins represent a promising platform for cancer immunotherapy. In this article, we briefly summarize recent advances in the understanding of circRNAs in tumor biology and immunology.
SN - 1476-4598
ER -